Literature DB >> 1697609

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

T Olsson1, W W Zhi, B Höjeberg, V Kostulas, Y P Jiang, G Anderson, H P Ekre, H Link.   

Abstract

Multiple sclerosis (MS) is a disease with unknown cause characterized by inflammation and demyelination in the central nervous system. Although an autoimmune pathogenesis has been suggested, there are no conclusive data on the number of T cells autoreactive with myelin antigens in MS compared to controls. We showed that T lymphocytes secreting interferon-gamma in response to possible target autoantigens are severalfold more common among PBL mononuclear cells in patients with MS than in patients with aseptic meningitis and tension headache. On average T cells reactive with myelin basic protein (MBP), two different MBP peptides, or with proteolipid protein amounted to 2.7-5.2/10(5) PBL from MS patients. MBP-reactive T cells were still more frequent among mononuclear cells isolated from the cerebrospinal fluid (CSF; 185/10(5) CSF cells). We concluded that T cells reactive with myelin autoantigens are strongly increased in MS. This approach to detect them could allow definition of immunodominant T cell epitopes in individual MS patients, and thereby enable further development towards specific immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697609      PMCID: PMC296818          DOI: 10.1172/JCI114800

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic.

Authors:  A M Duijvestijn; A B Schreiber; E C Butcher
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides.

Authors:  S Buus; A Sette; S M Colon; C Miles; H M Grey
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

Review 3.  The basis for the immunoregulatory role of macrophages and other accessory cells.

Authors:  E R Unanue; P M Allen
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

4.  Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis.

Authors:  D Johnson; D A Hafler; R J Fallis; M B Lees; R O Brady; R H Quarles; H L Weiner
Journal:  J Neuroimmunol       Date:  1986-11       Impact factor: 3.478

5.  Human T-cell response to myelin basic protein in multiple sclerosis patients and healthy subjects.

Authors:  E Tournier-Lasserve; G A Hashim; M A Bach
Journal:  J Neurosci Res       Date:  1988       Impact factor: 4.164

6.  Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosis.

Authors:  C N Baxevanis; G J Reclos; C Servis; E Anastasopoulos; P Arsenis; A Katsiyiannis; N Matikas; J D Lambris; M Papamichail
Journal:  J Neuroimmunol       Date:  1989-03       Impact factor: 3.478

7.  Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system.

Authors:  H S Panitch; R L Hirsch; J Schindler; K P Johnson
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

8.  Peptide specificities of myelin basic protein-reactive human T-cell clones.

Authors:  J R Richert; C A Reuben-Burnside; G E Deibler; M W Kies
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

9.  Myelin basic protein-specific CD4+ cytolytic T-lymphocyte clones isolated from multiple sclerosis patients.

Authors:  W E Weber; W A Buurman
Journal:  Hum Immunol       Date:  1988-06       Impact factor: 2.850

10.  Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.

Authors:  D A Hafler; D S Benjamin; J Burks; H L Weiner
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

View more
  62 in total

1.  In vivo priming of IL-17(+) uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via γδ T cell activation.

Authors:  Aijun Zuo; Dongchun Liang; Hui Shao; Willi K Born; Henry J Kaplan; Deming Sun
Journal:  Mol Immunol       Date:  2012-02-01       Impact factor: 4.407

2.  miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.

Authors:  Kristen M Smith; Mireia Guerau-de-Arellano; Stefan Costinean; Jessica L Williams; Arianna Bottoni; Gina Mavrikis Cox; Abhay R Satoskar; Carlo M Croce; Michael K Racke; Amy E Lovett-Racke; Caroline C Whitacre
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

3.  The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

Authors:  Ana M Sanchez; Wes Rountree; Mark Berrong; Ambrosia Garcia; Alexandra Schuetz; Josephine Cox; Nicole Frahm; Mark Manak; Marcella Sarzotti-Kelsoe; M Patricia D'Souza; Thomas Denny; Guido Ferrari
Journal:  J Immunol Methods       Date:  2014-03-28       Impact factor: 2.303

4.  Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities.

Authors:  Cassandra E Smith; Stephen D Miller
Journal:  J Autoimmun       Date:  2006-12       Impact factor: 7.094

5.  FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4(+) CD25(high) T cells in multiple sclerosis.

Authors:  F Sellebjerg; M Krakauer; M Khademi; T Olsson; P S Sørensen
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

6.  Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

Authors:  M Comabella; K Balashov; S Issazadeh; D Smith; H L Weiner; S J Khoury
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis.

Authors:  Priscilla W Lee; Yuhong Yang; Michael K Racke; Amy E Lovett-Racke
Journal:  Brain Behav Immun       Date:  2014-12-10       Impact factor: 7.217

8.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk.

Authors:  Katarina Tengvall; Jesse Huang; Cecilia Hellström; Patrick Kammer; Martin Biström; Burcu Ayoglu; Izaura Lima Bomfim; Pernilla Stridh; Julia Butt; Nicole Brenner; Angelika Michel; Karin Lundberg; Leonid Padyukov; Ingrid E Lundberg; Elisabet Svenungsson; Ingemar Ernberg; Sigurgeir Olafsson; Alexander T Dilthey; Jan Hillert; Lars Alfredsson; Peter Sundström; Peter Nilsson; Tim Waterboer; Tomas Olsson; Ingrid Kockum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-02       Impact factor: 11.205

9.  High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) are present in cord blood.

Authors:  M Yu; S Fredrikson; J Link; H Link
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Target epitopes of myelin basic protein specific T cell lines in multiple sclerosis.

Authors:  G Ristori; M Salvetti; C Buttinelli; M Falcone; S Trabace; C Fieschi
Journal:  Ital J Neurol Sci       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.